Product News and Recalls

FDA proposes warning labels for tanning beds

The U.S. Food and Drug Administration has proposed requiring tanning beds to include a label warning that the devices increase the risk of skin cancer and shouldn’t be used by people younger than 18.

According to a USA Today story, the FDA currently regulates the sunlamps in tanning beds as class 1 devices, which are considered low risk and don’t require review before going on the market.

The FDA’s proposal would change ...

continue reading...

Vaginal mesh recipients protest outside hospital

A story in the Star Phoenix describes a protest outside a Canadian hospital by women warning others about a medical device called the vaginal mesh implant.

The implant is supposed to treat urinary incontinence and pelvic organ prolapse, a condition characterized by weakened muscles being unable to provide adequate support for the pelvic organs.

But the protest included women who have suffered serious complications from the mesh, which ...

continue reading...

Woman describes health problems from Mirena IUD

In a piece for Australian paper The Border Mail, writer Bianca Wordley describes the problems she experienced as a result of using Bayer’s Mirena intrauterine device.

While Wordley acknowledges that not every woman who gets Mirena implanted has problems with it, in her case it was “a dreadful mistake.”

In the United States, a number of women have filed lawsuits claiming the company overstated the device’s benefits in its advertising while trying ...

continue reading...

Statins may cause risk of muscular injury

A new study has concluded that the class of cholesterol-lowering medications known as statins, which include Lipitor, may put users at greater risk of muscular injury.

A story in The Telegraph quotes researcher Dr. Ishak Mansi of the North Texas Health Care System in Dallas as saying: “Musculoskeletal conditions, arthropathies, injuries and pain are more common among statin users than among similar non-users. The full spectrum of statins’ musculoskeletal adverse events ...

continue reading...

Study: Lipitor diabetes risk higher than some other statins

While a recent study by Canadian researchers found a link between certain types of statins and Type 2 diabetes, the news wasn’t universally bad for users of the popular anti-cholesterol drugs.

A story in U.S. News and World Report says the researchers identified stronger statins including Lipitor as problematic.

But other types of statins performed more favorably in terms of diabetes. Study authors wrote that some forms of the drugs may even ...

continue reading...

Investors cautioned against Merck

An item on investing blog Seeking Alpha advises readers not to own stock in the pharmaceutical company Merck, in part because of safety risks associated with its products.

The item mentions a recent study published in the medical journal JAMA Internal Medicine. Researchers concluded that a type of drugs for type 2 diabetes called GLP-1 atagonists, which include Merck’s Januvia and Bristol-Myers Squibb’s Byetta, double a patient’s chances of developing pancreatitis. ...

continue reading...
Page 229 of 386 «...200210220227228229230231...»